Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000891092-17-001364
Filing Date
2017-02-14
Accepted
2017-02-14 17:05:08
Documents
2
Group Members
JEREMY MINDICHMATTHEW SIROVICHSCOPIA MANAGEMENT, INC.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A e73031sc13ga.htm SC 13G/A 148187
2 JOINT FILING AGREEMENT e73031ex99-1.htm EX-99.1 6489
  Complete submission text file 0000891092-17-001364.txt   156585
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Subject) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-48577 | Film No.: 17610176
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 152 WEST 57TH STREET 33RD FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 33RD FLOOR NEW YORK NY 10019 212-370-0303
SCOPIA CAPITAL MANAGEMENT LP (Filed by) CIK: 0001279150 (see all company filings)

EIN.: 300711986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A